Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-24-006398
Filing Date
2024-11-12
Accepted
2024-11-12 09:31:31
Documents
2

Document Format Files

Seq Description Document Type Size
1 ALIGOS THERAPEUTICS, INC. p24-3089sc13g.htm SC 13G 70320
2 JOINT FILING AGREEMENT PURSUANT TO RULE 13D-1(K) p24-3089exhibit99.htm EX-99.1 3129
  Complete submission text file 0000902664-24-006398.txt   75044
Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116 617-867-2800
Adage Capital Management, L.P. (Filed by) CIK: 0001535978 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Subject) CIK: 0001799448 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91770 | Film No.: 241444193
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)